No Data
No Data
Analysts Are Neutral on These Healthcare Stocks: SAGE Therapeutics (SAGE), Adverum Biotechnologies (ADVM)
Adverum Biotechnologies Files for $200M Mixed Securities Shelf
Express News | Trading Halt: Halt Status Updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
Positive Outlook for Adverum Biotechnologies With Upcoming Ixo-vec Milestones and Strong Financial Position
Adverum Biotechnologies Reports Encouraging Clinical Progress Amidst Financial Adjustments
Brexit Uncertainty: Navigating New Risks and Regulatory Hurdles for Adverum Biotechnologies
No Data
QianmengYu : nice!
QianmengYu : drop to halt. Hmmm